A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-Induced Dementia

Total Page:16

File Type:pdf, Size:1020Kb

A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-Induced Dementia Acta Scientific NUTRITIONAL HEALTH (ISSN:2582-1423) Volume 5 Issue 7 July 2021 Research Article Jasonia Montana; A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-induced Dementia Mohammed A Hussein1*, Nada M El-Laban1, Lamiaa H Elabody1, Received: April 22, 2021 Amany M Ghazal1, Basant S Mohamed1, Azhar A Mohamed1, Lamiaa Y June 11, 2021 Elhalafwy1, Sanaa M Elsayad1, Amal S Othman2 and Ali A Ali3 Published: © All rights are reserved by Mohammed A 1Department of Biochemistry, Faculty of Applied Medical Science, October 6th Hussein., et al. University, Egypt 2Department of Med Labs, Faculty of Applied Medical Science, October 6th University, Egypt 3Vice President of Post Graduate Studies, October 6 University, Egypt *Corresponding Author: Mohammed A Hussein, Professor of Biochemistry and Medical Sciences, October 6 University, Egypt. Vice Dean for Post-graduate Studies and Scientific Research, Faculty of Applied Abstract Neurodegenerative disorder clinically characterized by progressive cognitive and memory dysfunction. This study investigated the effect of Jasonia montana ethanolic extract (JMEE) on Ca-, Mg+2 and Na+, K+-ATPase and acetylcholinesterase (AChE) activities as well as β amyloid1-42 level in brain hippocampus of adult rats exposed to SCO. Rats were exposed to SCO (3.0 mg/Kg) and JMEE (150 mg/Kg) by gavage for 14 days. Rats were randomly divided into six groups with 6 rats in each: [Saline], [saline/SCO (3.0 mg/ kg)], [saline/SCO (3.0 mg/kg)/JMEE (150 mg/kg,)], [saline/SCO (3.0 mg/kg)/ DHC (3 mg/kg)] and [saline/SCO (3.0 mg/kg)/JMEE (150 mg/kg,)/ DHC (3 mg/kg)]. Results demonstrated that plasma TC, TG as well as brain hippocampus levels of AChE, MAO, βA1-42, +2, Mg+2 and Na+, K+ - TBARS. Also, the results showed that a significant depletion of plasma HDL-C as well as brain hippocampus levels of phospholipids, +2, Mg+2 GSH, ACh, Ca -ATPase. Treatment with JMEE (150 mg/Kg) prevented the increase in TC, TG, AChE, MAO, β amy and Na+, K+ loid1-42, TBARS activity when compared to SCO-treated group. JMEE treatment prevented the SCO-induced decrease in Ca Our data showed that JMEE have a protector effect against SCO induced neurodegenerative. Also, Jasonia Montana is a promising -ATPase activities as well as GSH, HDL-C, ACh and phospholipids in SCO-treated group when compared to normal group. therapeutic agent to attenuate neurological disorders associated with SCO induced dementia. Keywords: Jasonia Montana; Antioxidant; Scopolamine; Acetylcholine Esterase; Monoamine Oxidase and Dementia Abbreviations - - β amyloid1-42; TBARS: Thiobarbaturic Acid Reactive Substances; JMEE: Jasonia Montana Ethanolic Extract; DHC: Donepezil Hydro tathione. HDL-C: Cholesterol-High Density Lipoprotein; GHS: Reduced Glu chloride; AChE: Acetylcholinesterase; SCO: Scopolamine; TC: Total Cholesterol; TG: Triglycerides; MAO: Monoamine Oxidase; βA1-42: Citation: Mohammed A Hussein., et al. “Jasonia Montana; A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-induced Dementia". Acta Scientific Nutritional Health 5.7 (2021): 27-37. Jasonia Montana; A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-induced Dementia Introduction its antioxidant , hypoglycemic , anticholestatic and28 anti-obesity activities. But there are no reports of the neuro- Neurodegenerative diseases are an incurable group of degen- [30] [31] [32] protective effect of Jasonia Monta. The present study was under- erative disorders. They are characterized by loss of neuronal cells, [33] leading to progressive impairments of functions of central nervous taken to investigate the investigated the effect of Jasonia Montana system (CNS) . Neurons are affected when a genetic mutation is extract antioxidant activity against scopolamine induced neurotox- - icity. [1] tations in amyloid precursor protein (APP) or presenilin 1 (PSEN1) identified in a ubiquitously expressed gene. For examples, the mu Materials and Methods and 2 (PSEN2) that occur in Alzheimer's disease (AD) , which Chemicals affect learning and memory circuits . [1] Scopolamine hydrobromide and donepezil hydrochloride was However, during aging and various[2,3] disease states, antioxidant defense systems can be altered leading to progressive oxidative obtained from Sigma Chemical Co. (St. Louis MO, USA). - Plant material tion . The brain is particularly sensitive to oxidative stress damage and subsequent cell death and/or significant loss of func - [4,5] Fresh aerial parts of J. Montana were collected from the Sinai acids, high oxygen consumption per unit of weight, high content since it presents: high content of peroxidizable unsaturated fatty Peninsula the plant was identified by Prof. Heba A. Elgizawy, Phar - macognosy department, Faculty of Pharmacy, October 6 University. Preparation of ethanolic extract in iron and ascorbate (LPO key ingredients) and a scarcity of an Air-dried aerial parts of the plant (1.5 kg) was crushed to coarse . In humans, the brain accounts for only a few percent of the tioxidant defense systems (e.g. GSH, GPx, CAT and vitamin E) [6- body weight, but it processes 20 % of basal oxygen consumption. A 11] The extract was concentrated under reduced pressure to yield vis- neuron uses much of oxygen via mitochondrial respiratory chain to powder and extracted exhaustively in a Soxhlet with 95% ethanol. cous mass. The ethanolic extract was kept in airtight containers in make ATP for maintaining low gradients . oC until the time of further use. [12,13] a deep freeze maintained at 4 agents in a multitude of disease states , most commonly Phytochemical screening Plant-derived polyphenols have been implicated as beneficial cancer, cardiovascular disease, and neurodegenerative disorders. A phytochemical analysis of aerial parts of J. Montana was con- [14,15] - lying these disorders and thus slowing the disease progression - Flavonoids are also able to counteract the neuronal injury under ducted for the detection of alkaloids, cardiac glycosides, flavonoids, terpenes . They have been shown to be effective at blocking oxidant- tannins, anthraquinones, saponins, volatile oil, coumarins and tri , although not via direct radical or [34]. [16,17] Animals oxidant-scavenging activity . induced neuronal injury [18] Adult albino rats weighing around 150 ± 10 gms, at the age of 10 [19,20] - weeks were purchased from National Cancer Institute, Cairo Uni- eas , including the Sinai Peninsula . The herb has a strong versity. They were acclimatized to animal house conditions. Ani- Jasonia Montana occurs in the Mediterranean and adjacent ar aromatic odor and is used in traditional medicine for diarrhea, [21] [22] stomachache, and chest diseases . were kept under constant environmental condition and observed mals were provided with standard diet and water ad libtum. Rats daily throughout the experimental work. Polyphenols [23] , and essential oils have been reported from Jasonia Mon- Experimental design [24], mono- and sesquiterpenes [25], flavonoids tana represent a promising potential species . These polyphe- [26] [27] nols are more potent antioxidants than vitamins C and E . Also, - [28] The rats were randomized and divided into five groups of six of the aerial parts of J. Montana was reported. In-vivo tests have mencement of experiment. The animals were divided into the fol- [29] rats each. Food was withdrawn 24 h and water 2 h before the com been conducted with Jasonia Montana to determine, for example, lowing groups (Table 1). Citation: Mohammed A Hussein., et al. “Jasonia Montana; A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-induced Dementia". Acta Scientific Nutritional Health 5.7 (2021): 27-37. Jasonia Montana; A Promising Therapeutic Agent to Attenuate Neurological Disorders Associated with SCO-induced Dementia o C using a cooling ultra-centrifuge29 No. Groups Treatment Description gated at 10500 xg for 15 min at 4 I Normal control was used for the determination of Ca+2, Mg+2, Na+, K+-ATPase activi- (Sorvall comiplus T-880, Du Pont, USA), and the clear supernatant Received 5 mL saline orally, daily for 14 days. II Disease control according to Tokeo and Sakanashi method - Received Scopolamine ties. The fourth aliquot used to extract and separate phospholipids hydrobromide (SCO) (3 mg/kg.b.w. [40]. Briefly, 1 mg of ho i.p), daily for 14 days [35]. mogenized tissue was treated with 950 μL of chloroform: methanol J. Montana ethanolic extract (150 III Treated group (A) Received SCO (3 mg/kg.b.w. i.p.) + (2:1, v: v) solution containing butylated hydroxytoluene (2 mM) and 50 μL of potassium phosphate buffer (100 mM, pH 7.4). The mg/kg b.w. orally) daily for 14 fifth aliquot was centrifuged at 5000 xg, and the supernatant was days [32]. analysis was run in parallel to test samples. The absorbance was donepezil used for the detection of β – Amyloid (Aβ1-42). Standard curve IV Treated group (B) Received SCO (3 mg/kg.b.w.i.p.) + measured in the multi-scan spectrum spectrophotometer (Thermo hydrochloride (3 mg/kg, orally) were performed in triplicate. daily for 14 days [36]. Scientific, Multiskan GO) at optical density 450 nm. All the readings J. Montana ethanolic extract (150 V Treated group (C) Received SCO (3 mg/kg.b.w. i.p.) + Histological assessment mg/kg b.w. orally) + donepezil 10% buffered formaldehyde solution for histological study. The hydrochloride (3 mg/kg, orally). The brain hippocampus was sliced, and pieces were fixed in Table 1: - Groups of animals in the present study. fixed tissues were processed by automated tissue processing ma Plasma lipid profile estimation methods. Sections of 5 lm in thickness were prepared and then chine. Tissues were embedded in paraffin wax by conventional On 15th day, blood was collected from the retro-orbital vein of stained with hematoxylin and eosin for light microscopy analyses each animal and each sample was collected into heparinized tubes, according to the method of Bancroft and Steven . After that, the centrifuged, and plasma was used freshly for estimation of plasma sections were observed under the microscope for histopathologi- [41] cal changes, and their photomicrographs were captured.
Recommended publications
  • Asteraceae)§ Karin M.Valant-Vetscheraa and Eckhard Wollenweberb,*
    Chemodiversity of Exudate Flavonoids in Seven Tribes of Cichorioideae and Asteroideae (Asteraceae)§ Karin M.Valant-Vetscheraa and Eckhard Wollenweberb,* a Department of Plant Systematics and Evolution Ð Comparative and Ecological Phytochemistry, University of Vienna, Rennweg 14, A-1030 Wien, Austria b Institut für Botanik der TU Darmstadt, Schnittspahnstrasse 3, D-64287 Darmstadt, Germany. E-mail: [email protected] * Author for correspondence and reprint requests Z. Naturforsch. 62c, 155Ð163 (2007); received October 26/November 24, 2006 Members of several genera of Asteraceae, belonging to the tribes Mutisieae, Cardueae, Lactuceae (all subfamily Cichorioideae), and of Astereae, Senecioneae, Helenieae and Helian- theae (all subfamily Asteroideae) have been analyzed for chemodiversity of their exudate flavonoid profiles. The majority of structures found were flavones and flavonols, sometimes with 6- and/or 8-substitution, and with a varying degree of oxidation and methylation. Flava- nones were observed in exudates of some genera, and, in some cases, also flavonol- and flavone glycosides were detected. This was mostly the case when exudates were poor both in yield and chemical complexity. Structurally diverse profiles are found particularly within Astereae and Heliantheae. The tribes in the subfamily Cichorioideae exhibited less complex flavonoid profiles. Current results are compared to literature data, and botanical information is included on the studied taxa. Key words: Asteraceae, Exudates, Flavonoids Introduction comparison of accumulation trends in terms of The family of Asteraceae is distributed world- substitution patterns is more indicative for che- wide and comprises 17 tribes, of which Mutisieae, modiversity than single compounds. Cardueae, Lactuceae, Vernonieae, Liabeae, and Earlier, we have shown that some accumulation Arctoteae are grouped within subfamily Cichori- tendencies apparently exist in single tribes (Wol- oideae, whereas Inuleae, Plucheae, Gnaphalieae, lenweber and Valant-Vetschera, 1996).
    [Show full text]
  • Plant Flavonoids As Potential Source of Future Antimalarial Leads
    Sys Rev Pharm. 2017;8(1):13-18 Review Article A multifaceted Review journal in the field of Pharmacy Plant Flavonoids as Potential Source of Future Antimalarial leads Mithun Rudrapal* and Dipak Chetia Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786004, Assam, INDIA. ABSTRACT In this article, a comprehensive review on bioactive flavonoids that are lishing plant flavonoids as future antimalarial leads for the development of abundant in medicinal and functional food (dietary) plants has been made, new and potent antimalarial drug molecules. with special reference to antimalarial flavonoid molecules. Flavonoids have Key words: Malaria, P. falciparum, Drug resistance, Flavonoids, Leads, An- been found to exist in plants/plant medicines comprising numerous poly- timalarial. phenolic compounds with a wide structural diversity having pharmacologi- cal potential in diverse range of therapeutic areas. Flavonoids derived from Correspondence: certain dietary plants described herein have been investigated for their an- Mithun Rudrapal timalarial effectiveness against malaria parasites, particularly Plasmodium Department of Pharmaceutical Sciences, Dibrugarh University, Dibru- falciparum. The biological target specificity of their antimalarial action is so garh-786004, Assam, India interesting that they act at protein targets at molecular level other than the Email: [email protected] conventional antimalarial targets. This approach may be a basis of estab- DOI : 10.5530/srp.2017.1.4 INTRODUCTION Malaria is a serious
    [Show full text]
  • Flavonoids from Artemisia Annua L. As Antioxidants and Their Potential Synergism with Artemisinin Against Malaria and Cancer
    Molecules 2010, 15, 3135-3170; doi:10.3390/molecules15053135 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer 1, 2 3 4 Jorge F.S. Ferreira *, Devanand L. Luthria , Tomikazu Sasaki and Arne Heyerick 1 USDA-ARS, Appalachian Farming Systems Research Center, 1224 Airport Rd., Beaver, WV 25813, USA 2 USDA-ARS, Food Composition and Methods Development Lab, 10300 Baltimore Ave,. Bldg 161 BARC-East, Beltsville, MD 20705-2350, USA; E-Mail: [email protected] (D.L.L.) 3 Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA; E-Mail: [email protected] (T.S.) 4 Laboratory of Pharmacognosy and Phytochemistry, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium; E-Mail: [email protected] (A.H.) * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 26 January 2010; in revised form: 8 April 2010 / Accepted: 19 April 2010 / Published: 29 April 2010 Abstract: Artemisia annua is currently the only commercial source of the sesquiterpene lactone artemisinin. Since artemisinin was discovered as the active component of A. annua in early 1970s, hundreds of papers have focused on the anti-parasitic effects of artemisinin and its semi-synthetic analogs dihydroartemisinin, artemether, arteether, and artesunate. Artemisinin per se has not been used in mainstream clinical practice due to its poor bioavailability when compared to its analogs. In the past decade, the work with artemisinin-based compounds has expanded to their anti-cancer properties.
    [Show full text]
  • WO 2018/002916 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL).
    [Show full text]
  • Investigation of the in Vitro Bioavailability of Luteolin from Modified Preparations of Artemisia Afra
    Investigation of the in vitro bioavailability of luteolin from modified preparations of Artemisia afra Anjong Nkengla A thesis submitted in fulfilment of the requirements for the degree of Magister Scientiae (Pharmaceutical Sciences) in the Discipline of Pharmacology at the University of the Western Cape, Bellville, South Africa. Supervisor: Prof. James A. Syce December 2014 Investigation of the in vitro bioavailability of luteolin from modified preparations of Artemisia afra Anjong Nkengla Key words Artemisia afra Flavonoid Luteolin Permeability Freeze dried Alginate Polymethylmethacrylate Single pass intestinal perfusion HPLC ii Summary Artemisia afra (A. afra) is traditionally used for a variety of ailments and contain flavonoids e.g. luteolin which may contribute to some of its activity. It is generally administered as a tea or decoction, and such liquid dosage forms present challenges as far as long term storage and stability are concerned, as well as sub-optimal oral bioavailability of actives they contain. Freeze dried aqueous extracts (FDAE) can alleviate such problems but may be hygroscopic and unstable. The use of modified forms of FDAE can counter the problem of hygroscopicity (e.g. use of alginate) and alleviate the issue of sub-optimal bioavailability of plant actives (e.g. polymethylmethacrylate). The objectives of this study, were to: (1) prepare the freeze dried aqueous extract (FDAE) and modified forms, which include alginate-extract beads (alginate-FDAE) and polymethylmethacrylate coated alginate matrix beads of herbal extract (PMMA-alginate-FDAE) of the FDAE of A. afra, (2) determine and compare the pharmaceutical characteristics of the above mentioned preparations of A. afra,(3) quantify and compare the total flavonoid and specifically luteolin levels of the different forms of A.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis Chemical Activity Count (+)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (+)-8HYDROXYCALAMENENE 1 (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 3 (+)-AROMOLINE 1 (+)-CASSYTHICINE 1 (+)-CATECHIN 10 (+)-CATECHIN-7-O-GALLATE 1 (+)-CATECHOL 1 (+)-CEPHARANTHINE 1 (+)-CYANIDANOL-3 1 (+)-EPIPINORESINOL 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALBACIN 2 (+)-GALLOCATECHIN 3 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 2 (+)-T-CADINOL 1 (+)-VESTITONE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (-)-ACANTHOCARPAN 1 (-)-ALPHA-BISABOLOL 2 (-)-ALPHA-HYDRASTINE 1 Chemical Activity Count (-)-APIOCARPIN 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-CANESCACARPIN 1 (-)-CENTROLOBINE 1 (-)-CLANDESTACARPIN 1 (-)-CRISTACARPIN 1 (-)-DEMETHYLMEDICARPIN 1 (-)-DICENTRINE 1 (-)-DOLICHIN-A 1 (-)-DOLICHIN-B 1 (-)-EPIAFZELECHIN 2 (-)-EPICATECHIN 6 (-)-EPICATECHIN-3-O-GALLATE 2 (-)-EPICATECHIN-GALLATE 1 (-)-EPIGALLOCATECHIN 4 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 9 (-)-EUDESMIN 1 (-)-GLYCEOCARPIN 1 (-)-GLYCEOFURAN 1 (-)-GLYCEOLLIN-I 1 (-)-GLYCEOLLIN-II 1 2 Chemical Activity Count (-)-GLYCEOLLIN-III 1 (-)-GLYCEOLLIN-IV 1 (-)-GLYCINOL 1 (-)-HYDROXYJASMONIC-ACID 1 (-)-ISOSATIVAN 1 (-)-JASMONIC-ACID 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-MEDICARPIN 1 (-)-VESTITOL 1 (-)-VESTITONE 1
    [Show full text]
  • Safety Assessment of Chamomilla Recutita-Derived Ingredients As Used in Cosmetics
    PINK Safety Assessment of Chamomilla Recutita-Derived Ingredients as Used in Cosmetics Status: Draft Tentative Report for Panel Review Release Date: August 16, 2013 Panel Date: September 9-10, 2013 The 2013 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1101 17TH STREET, NW, SUITE 412 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ CIRINFO@CIR- SAFETY.ORG Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: August 16, 2013 Subject: Draft Tentative Report on the Chamomilla Recutita-Derived Ingredients At the June 10-11, 2013 CIR Expert Panel meeting, the Panel determined that the available data are insufficient for evaluating the safety of the Chamomilla recutita-derived ingredients in cosmetic products and that the following data are needed: Skin irritation and sensitization data on chamomilla recutita (matricaria) flower extract at a use concentration of 10%. As noted in the data listed below, human skin irritation and sensitization data on products containing 0.3% and 0.2% chamomilla recutita (matricaria) flower extract, respectively, were received.
    [Show full text]
  • In Silico, in Vitro and in Vivo Memory Enhancing Activity
    IN SILICO, IN VITRO AND IN VIVO MEMORY ENHANCING ACTIVITY OF CERTAIN COMMERCIALLY AVAILABLE FLAVONOIDS IN SCOPOLAMINE AND ALUMINIUM-INDUCED LEARNING IMPAIRMENT IN MICE Thesis submitted to The Tamil Nadu Dr. M.G.R. Medical University, Chennai for the award of the degree of DOCTOR OF PHILOSOPHY in PHARMACY Submitted by A. MADESWARAN, M. Pharm., Under the guidance of Dr. K. ASOK KUMAR, M. Pharm., Ph.D. College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore – 641 044, Tamil Nadu, India. JUNE 2017 Certificate This is to certify that the Ph.D. dissertation entitled “IN SILICO, IN VITRO AND IN VIVO MEMORY ENHANCING ACTIVITY OF CERTAIN COMMERCIALLY AVAILABLE FLAVONOIDS IN SCOPOLAMINE AND ALUMINIUM- INDUCED LEARNING IMPAIRMENT IN MICE” being submitted to The Tamil Nadu Dr. M.G.R. Medical University, Chennai, for the award of degree of DOCTOR OF PHILOSOPHY in the FACULTY OF PHARMACY was carried out by Mr. A. MADESWARAN, in College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, under my direct supervision and guidance to my fullest satisfaction. The contents of this thesis, in full or in parts, have not been submitted to any other Institute or University for the award of any degree or diploma. Dr. K. Asok Kumar, M.Pharm., Ph.D. Professor & Head, Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu - 641 044. Place: Coimbatore – 44. Date: Certificate This is to certify that the Ph.D. dissertation entitled “IN SILICO, IN VITRO AND IN VIVO MEMORY ENHANCING ACTIVITY OF CERTAIN COMMERCIALLY AVAILABLE FLAVONOIDS IN SCOPOLAMINE AND ALUMINIUM- INDUCED LEARNING IMPAIRMENT IN MICE” being submitted to The Tamil Nadu Dr.
    [Show full text]
  • Molecules 2010, 15, 3135-3170; Doi:10.3390/Molecules15053135
    Molecules 2010, 15, 3135-3170; doi:10.3390/molecules15053135 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer 1, 2 3 4 Jorge F.S. Ferreira *, Devanand L. Luthria , Tomikazu Sasaki and Arne Heyerick 1 USDA-ARS, Appalachian Farming Systems Research Center, 1224 Airport Rd., Beaver, WV 25813, USA 2 USDA-ARS, Food Composition and Methods Development Lab, 10300 Baltimore Ave,. Bldg 161 BARC-East, Beltsville, MD 20705-2350, USA; E-Mail: [email protected] (D.L.L.) 3 Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA; E-Mail: [email protected] (T.S.) 4 Laboratory of Pharmacognosy and Phytochemistry, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium; E-Mail: [email protected] (A.H.) * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 26 January 2010; in revised form: 8 April 2010 / Accepted: 19 April 2010 / Published: 29 April 2010 Abstract: Artemisia annua is currently the only commercial source of the sesquiterpene lactone artemisinin. Since artemisinin was discovered as the active component of A. annua in early 1970s, hundreds of papers have focused on the anti-parasitic effects of artemisinin and its semi-synthetic analogs dihydroartemisinin, artemether, arteether, and artesunate. Artemisinin per se has not been used in mainstream clinical practice due to its poor bioavailability when compared to its analogs. In the past decade, the work with artemisinin-based compounds has expanded to their anti-cancer properties.
    [Show full text]
  • Stevia Genus: Phytochemistry and Biological Activities Update
    molecules Review Stevia Genus: Phytochemistry and Biological Activities Update Jimena Borgo 1,2,3, Laura C. Laurella 1,2, Florencia Martini 1,3, Cesar A. N. Catalán 4 and Valeria P. Sülsen 1,2,3,* 1 Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET—Universidad de Buenos Aires, Buenos Aires 1113, Argentina; [email protected] (J.B.); [email protected] (L.C.L.); fl[email protected] (F.M.) 2 Cátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina 3 Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires 1113, Argentina 4 Instituto de Química Orgánica, Facultad de Bioquímica Química y Farmacia, Universidad Nacional de Tucumán, Ayacucho 471 (T4000INI), San Miguel de Tucumán T4000, Argentina; [email protected] * Correspondence: [email protected] Abstract: The Stevia genus (Asteraceae) comprises around 230 species, distributed from the southern United States to the South American Andean region. Stevia rebaudiana, a Paraguayan herb that produces an intensely sweet diterpene glycoside called stevioside, is the most relevant member of this genus. Apart from S. rebaudiana, many other species belonging to the Stevia genus are considered medicinal and have been popularly used to treat different ailments. The members from this genus produce sesquiterpene lactones, diterpenes, longipinanes, and flavonoids as the main types of phytochemicals. Many pharmacological activities have been described for Stevia extracts and isolated compounds, antioxidant, antiparasitic, antiviral, anti-inflammatory, and antiproliferative activities being the most frequently mentioned. This review aims to present an update of the Stevia genus covering ethnobotanical aspects and traditional uses, phytochemistry, and biological activities of the Citation: Borgo, J.; Laurella, L.C.; extracts and isolated compounds.
    [Show full text]
  • Artemisia Annua
    Project number: PZW-AAF4 Post-harvest Storage Stability of Artemisinin and Flavonoids in Artemisia annua A Major Qualifying Project Report: Submitted to the Faculty Of the WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree of Bachelor of Science by _________________________ _________________________ Meredith Ghilardi Jason Purnell Date: Approved: ________________________ Prof. Pamela J. Weathers, Major Advisor Acknowledgements We would like to thank Dr. Pamela Weathers for support and guidance for this project. We would also like to thank Dr. Melissa Towler for all of her help and guidance in the lab. We would like to thank the graduate students Sibo Wang and Liwen Fei for their help in the lab. 1 Contents Acknowledgements ..................................................................................................................... 1 Abstract ....................................................................................................................................... 3 A. The Problem and Its Significance. ....................................................................................... 4 A.1.Artemisinin Biosynthesis. ................................................................................................. 9 A.2.Microbial Synthesis of Artemisinin. ............................................................................... 12 A.3. Peroxidases and Relationship to Artemisinin. ............................................................... 12 A.4. Catalase and its Relation
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Wound
    Dr.
    [Show full text]